Advanced company searchLink opens in new window

NEURAXPHARM UK LIMITED

Company number 10918621

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
30 Sep 2024 AA Full accounts made up to 31 December 2023
02 Sep 2024 CS01 Confirmation statement made on 15 August 2024 with no updates
21 Feb 2024 PSC02 Notification of Permira Vii Investment Platform Limited as a person with significant control on 16 December 2020
21 Feb 2024 PSC09 Withdrawal of a person with significant control statement on 21 February 2024
28 Sep 2023 AA Accounts for a small company made up to 31 December 2022
30 Aug 2023 CS01 Confirmation statement made on 15 August 2023 with no updates
19 Jan 2023 AP01 Appointment of Dr Maximilian Von Wülfing as a director on 10 January 2023
05 Jan 2023 TM01 Termination of appointment of Craig Andrew Bowen as a director on 5 January 2023
05 Jan 2023 TM01 Termination of appointment of Jan Christoph Koch as a director on 5 January 2023
09 Nov 2022 AP01 Appointment of Mr Mark Anthony Slater as a director on 10 October 2022
30 Sep 2022 AA Total exemption full accounts made up to 31 December 2021
30 Aug 2022 CS01 Confirmation statement made on 15 August 2022 with no updates
07 Apr 2022 CH01 Director's details changed for Mr Craig Andrew Bowen on 1 April 2022
01 Apr 2022 AD01 Registered office address changed from Unit 12 Farnborough Business Centre Eelmoor Farnborough Hampshire GU14 7XA United Kingdom to Tudor House 16 Cathedral Road Cardiff CF11 9LJ on 1 April 2022
11 Nov 2021 AAMD Amended total exemption full accounts made up to 31 December 2020
30 Sep 2021 AA Total exemption full accounts made up to 31 December 2020
21 Sep 2021 CS01 Confirmation statement made on 15 August 2021 with updates
18 Dec 2020 AA Total exemption full accounts made up to 31 December 2019
24 Aug 2020 CS01 Confirmation statement made on 15 August 2020 with updates
03 Oct 2019 AP01 Appointment of Mr Craig Andrew Bowen as a director on 27 September 2019
30 Sep 2019 AA Total exemption full accounts made up to 31 December 2018
12 Sep 2019 CS01 Confirmation statement made on 15 August 2019 with updates
11 Dec 2018 SH01 Statement of capital following an allotment of shares on 10 December 2018
  • GBP 305,000
26 Sep 2018 AA Accounts for a dormant company made up to 31 December 2017
20 Aug 2018 CS01 Confirmation statement made on 15 August 2018 with updates